Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review

Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulating A(H3N2) strains

(2014) Barbara Camilloni et al.   Immunity & Ageing

Long-term and cross-reactive immunogenicity of inactivated trivalent influenza vaccine in the elderly: MF59-adjuvanted vaccine versus unadjuvanted vaccine

(2013) Joon Young Song et al.   JOURNAL OF MEDICAL VIROLOGY

Immunogenicity and safety of Fluzone® intradermal and high-dose influenza vaccines in older adults ≥65 years of age: A randomized, controlled, phase II trial

(2013) Peter Tsang et al.   VACCINE

Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60

(2013) Filippo Ansaldi et al.   Human Vaccines & Immunotherapeutics

Safety, immunogenicity, and tolerability of three influenza vaccines in older adults

(2013) David W. Scheifele et al.   Human Vaccines & Immunotherapeutics

Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model

(2012) Laurent Coudeville et al.   BMC Medical Research Methodology

Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine

(2012) Carrie Reed et al.   VACCINE

Intanza® 15mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses

(2012) Filippo Ansaldi et al.   VACCINE

Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system

(2012) Giancarlo Icardi et al.   Human Vaccines & Immunotherapeutics

Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59®adjuvant

(2012) Giovanni Della Cioppa et al.   Human Vaccines & Immunotherapeutics

Serologic assays for influenza surveillance, diagnosis and vaccine evaluation

(2011) Jacqueline M Katz et al.   Expert Review of Anti-Infective Therapy

Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine

(2011) Paolo Durando et al.   Human vaccines & immunotherapeutics

Targeting human dendritic cell subsets for improved vaccines

(2011) Hideki Ueno et al.   SEMINARS IN IMMUNOLOGY

Influenza vaccine responses in older adults

(2010) Janet E. McElhaney   AGEING RESEARCH REVIEWS

Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study

(2010) Pierre Van Damme et al.   BMC INFECTIOUS DISEASES

Immunogenicity of Three Different Influenza Vaccines against Homologous and Heterologous Strains in Nursing Home Elderly Residents

(2010) Vincenzo Baldo et al.   Clinical & Developmental Immunology

MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk

(2010) Paolo Durando et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Intanza®: a new intradermal vaccine for seasonal influenza

(2010) Robert L Atmar et al.   Expert Review of Vaccines

MF59™ as a vaccine adjuvant: a review of safety and immunogenicity

(2010) Hana El Sahly   Expert Review of Vaccines

Designing Vaccines Based on Biology of Human Dendritic Cell Subsets

(2010) Karolina Palucka et al.   IMMUNITY

Changes in Human Langerhans Cells Following Intradermal Injection of Influenza Virus-Like Particle Vaccines

(2010) Marc Pearton et al.   PLoS One

Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates

(2010) Filippo Ansaldi et al.   VACCINE

An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home

(2010) B. Camilloni et al.   VACCINE

Intradermal influenza vaccine for older adults: A randomized controlled multicenter phase III study

(2009) Robert Arnou et al.   VACCINE

Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages

(2009) B. Camilloni et al.   VACCINE

Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice

(2008) Jean-François Nicolas et al.   Expert Review of Vaccines

Migratory and Lymphoid-Resident Dendritic Cells Cooperate to Efficiently Prime Naive CD4 T cells

(2008) Eric J. Allenspach et al.   IMMUNITY

MF59® -adjuvanted vaccines for seasonal and pandemic influenza prophylaxis

(2008) Angelika Banzhoff et al.   Influenza and Other Respiratory Viruses

Summer influenza outbreak in a home for the elderly: application of preventive measures

(2008) J. Gaillat et al.   JOURNAL OF HOSPITAL INFECTION

Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults: A Randomized Controlled Trial

(2008) David Holland et al.   JOURNAL OF INFECTIOUS DISEASES

Intradermal vaccine delivery: Will new delivery systems transform vaccine administration?

(2008) Paul Henri Lambert et al.   VACCINE

Cross-protection by MF59™-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses

(2008) Filippo Ansaldi et al.   VACCINE

Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects

(2008) Rongcheng Li et al.   Immunity & Ageing